http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017518772-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-999 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-1384 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0696 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-545 |
| filingDate | 2014-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2017518772-A |
| titleOfInvention | Method for producing induced pluripotent stem cells from adipose-derived mesenchymal stem cells and induced pluripotent stem cells produced by the method |
| abstract | The present invention relates to a medium composition for reverse differentiation of induced pluripotent stem cells containing bulges. The present invention also relates to a method for producing induced pluripotent stem cells using the medium composition. By using the medium composition according to the present invention, induced pluripotent stem cells can be efficiently and safely produced using adipose-derived mesenchymal stem cells, and the produced pluripotent stem cells can be used for various cells. Can be usefully used as a cell therapeutic agent. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7202610-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020094003-A |
| priorityDate | 2014-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 349.